Evidence map›Paper›PMID 39469267›Full record

ArticleERJ open research2024

Heart rate variability in pulmonary vascular disease at altitude: a randomised trial.

Joël J Herzig, Silvia Ulrich, Simon R Schneider, Julian Müller, Mona Lichtblau, Tanja L Ulrich, Meret Bauer, Michael Furian, Konrad E Bloch, Laura Mayer and 1 more

Abstract read
In one paragraph

Article in ERJ open research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Nocturnal Hypoxaemia in PAH Patients Living at High Altitude Relocated to Low Altitude.Respiration; international review of thoracic diseases · 2026
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Joël J HerzigDepartment of Pulmonology, University Hospital Zurich (USZ), Zurich, Switzerland.
Silvia UlrichDepartment of Pulmonology, University Hospital Zurich (USZ), Zurich, Switzerland.ORCID https://orcid.org/0000-0002-5250-5022
Simon R SchneiderDepartment of Pulmonology, University Hospital Zurich (USZ), Zurich, Switzerland.ORCID https://orcid.org/0000-0003-3635-0515
Julian MüllerDepartment of Pulmonology, University Hospital Zurich (USZ), Zurich, Switzerland.ORCID https://orcid.org/0000-0003-4059-5937
Mona LichtblauDepartment of Pulmonology, University Hospital Zurich (USZ), Zurich, Switzerland.ORCID https://orcid.org/0000-0003-4485-1758
Tanja L UlrichDepartment of Pulmonology, University Hospital Zurich (USZ), Zurich, Switzerland.
Meret BauerDepartment of Pulmonology, University Hospital Zurich (USZ), Zurich, Switzerland.
Michael FurianDepartment of Pulmonology, University Hospital Zurich (USZ), Zurich, Switzerland.ORCID https://orcid.org/0000-0002-8518-5029
Konrad E BlochDepartment of Pulmonology, University Hospital Zurich (USZ), Zurich, Switzerland.ORCID https://orcid.org/0000-0002-2377-7387
Laura MayerDepartment of Pulmonology, University Hospital Zurich (USZ), Zurich, Switzerland.
Esther I SchwarzDepartment of Pulmonology, University Hospital Zurich (USZ), Zurich, Switzerland.ORCID https://orcid.org/0000-0001-8840-981X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hypoxia is a trigger for sympathetic activation and autonomic cardiovascular dysfunction. Pulmonary vascular disease (PVD) is associated with hypoxaemia, which increases with altitude. The aim was to investigate how exposure of patients with PVD to hypobaric hypoxia at altitude affects autonomic cardiovascular regulation. Methods: In a randomised crossover study, patients with PVD were studied for 1 day and one night at an altitude of 2500 m (hypobaric hypoxia) and low altitude at 470 m in a random order. Outcomes were heart rate variability (HRV) in the time domain and in the frequency domain (low frequency (LF)/high frequency (HF) and LF/HF) and heart rate (HR) during day and night and baroreflex sensitivity (BRS). Results: In 25 patients with PVD (72% pulmonary arterial hypertension and 28% distal chronic thromboembolic pulmonary hypertension; mean±sd age 60.7±13.6 years), exposure to altitude resulted in significant increases in awake HR by 9.4 bpm (95% confidence interval (CI) 6.3-12.4, p<0.001) and nocturnal HR by 9.0 bpm (95% CI 6.6-11.4, p<0.001) and significant changes in awake and particularly nocturnal HRV indicating decreasing parasympathetic and increasing sympathetic activity (change in daytime LF/HF 1.7 (95% CI 0.6-2.8), p=0.004; nocturnal LF/HF 1.9 (95% CI 0.3-3.4), p=0.022) and a significant decrease in BRS (-2.4·mmHg Conclusion: Exposure of PVD patients to altitude resulted in a significant change in HRV indicating an increase in sympathetic activity and a decrease in BRS. The relative change in HRV at altitude was more pronounced during sleep.

Identifiers

PMID39469267
PMCPMC11514194

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.